Drug and Therapeutics Bulletin 1996;34:38-40; doi:10.1136/dtb.1996.34538
Copyright © 1996 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

From trial outcomes to clinical practice

There are compelling reasons to use evidence-based medicine when treating patients but for many people involved in patient management the interpretation of data can be difficult. The fourth annual Drug and Therapeutics Bulletin symposium 'From Trial Outcomes to Clinical Practice' which was held in March, addressed the difficulties. Here we summarise key points raised in the talks and discussion. We plan to publish the full proceedings in June.




This article has been cited by other articles:


Home page
 JAMAHome page
A. Pablos-Mendez, R. G. Barr, and S. Shea
Run-in Periods in Randomized Trials: Implications for the Application of Results in Clinical Practice
JAMA, January 21, 1998; 279(3): 222 - 225.
[Abstract] [Full Text] [PDF]


About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1996 BMJ Publishing Group Ltd.